Close Menu

NEW YORK (GenomeWeb) – Primerdesign, the molecular testing division of clinical diagnostics firm Novacyt, has made an agreement to develop an influenza and respiratory virus clinical assay with GenePOC, the firms announced today. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.